Pediatr. praxi. 2015;16(1):12-16

Thyroid associated orbitopathy in children

MUDr.Marcela Dvořáková, Ph.D.
Endokrinologický ústav, Praha

Thyroid associated orbitopathy is a chronic eyes disease associated with autoimmune reaction against the thyroid gland. Chronic

inflammation affectes all orbital structures- orbital fat and connective tissue, extraocular muscles, tear glands and orbital septum.

Increasing orbital volume cases eye replacement, disorder of the venous outflow and causes changes of the muscle elastic properties

which in turn start pulling the eyeball backwards. The patients with Graves-Basedow tyreotoxikosis are most often occured, less in

the chronic autoimmune thyroiditis. Incidence of the thyroid associated orbitopathy isn´t so frequent in children as in adults, the

forms aren´t so serious. Prompt and correct diagnosis, quick arrangement of the thyroid gland function, assessment of the activity

and seriousness of Graves orbitopathy and correct therapy is essential for other prognosis in children. A complex approach is for

treating EO necessary. The European Group of Graves´ Orbitopathy (EUGOGO) recommends that patiens should be treated in specialized

centres.

Keywords: Graves orbitopathy, thyroid associated orbitopathy, Graves hyperthyroidism

Published: February 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dvořáková M. Thyroid associated orbitopathy in children. Pediatr. praxi. 2015;16(1):12-16.
Download citation

References

  1. Lavard L, Ranlov I, et al. Incidence of juvenile tyreotoxicosis in Denmark 1982-1988. A nationwide study.EJE 1994; 130: 565-568. Go to original source... Go to PubMed...
  2. Bartley GB, Fatourechi V. The incidence of Graves' ophthalmopathy in Olmsted County. Minnesota.Am J. of Ophthalmopathy 1995; 120: 511-517. Go to original source... Go to PubMed...
  3. Dutta MK, Gundgurthi A, Garg MK, Kotwal N. Juvenile Graves' disease with opthalmopathy, lymphadenopathy, accelerated growth and congestive cardiac failure. Indian J Pediatr. 2012; 79(5): 670-672. Go to original source... Go to PubMed...
  4. Krassas GE, Segni M, Wiersinga WM. Childhood Graves' ophthalmopathy: results of a European questionnaire study. Eur J Endocrinol. 2005; 153(4): 515-521. Go to original source... Go to PubMed...
  5. Hrdá P, Novák Z, Šterzl I. Endokrinní orbitopatie. Farmakoterapie pro praxi/Sv.41, Praha Maxdorf, 2009: 109.
  6. Mourits MP, Koornneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves'ophthalmopathy: a novel approach. Br.J Ophthalmol 1989; 73: 639-644. Go to original source... Go to PubMed...
  7. Gogakos A, Boboridis K, Krassas GE. Pediatric aspects in Graves'orbitopathy. Pediatr Endocrinol Rev. 2010; 7(Suppl 2): 234-244. Go to PubMed...
  8. Bartalena L, Baldeschi L, Dickinson A, et al. European Group on Graves' Orbitopathy (EUGOGO). Consensus statement of the European Group on Graves' Orbitopathy of management of Graves' Orbitopathy. Eur J Endocrinol. 2008; 158(3): 273-285. Go to original source... Go to PubMed...
  9. Krassas GE. Wiersinga W. Smoking and autoimmune thyroid dinase: the plot thckens. Eur J Endocrinol. 2006; 154(6): 777-780. Go to original source... Go to PubMed...
  10. Krassas GE, Perros P. Prevention of thyroid associated-ophthalmopathy in children and adults: current views and management of preventable risk factors. Pediatr Endocrinol Rev. 2007; 4(3): 218-224. Go to PubMed...
  11. Krassas GE, Gogakos A. Thyroid-associated ophthalmopathy in juvenile Graves' disease-clinical, endocrine and therapeutic aspects. J Pediatr Endocrinol Metab. 2006; 19(10): 1193-206. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.